Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Daily News

Current NSAID Use Linked to Increased Risk of Heart Failure, Large European Analysis Shows

Michael O'Riordan

September 30, 2016

News Daily News

Were Problems With the Point-of-Care Device Used in ROCKET AF Kept From the FDA? BMJ Says Yes

September 28, 2016

News Daily News

Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes

Michael O'Riordan

August 12, 2016

News Daily News

Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings

Michael O'Riordan

July 12, 2016

News Daily News

ROCKET AF Investigators Respond to New Questions About Point-of-Care Warfarin Monitoring Device

July 08, 2016

News Features

Brooding Over Brexit: Cardiologists Voice Uncertainty About Effects on Collaboration, Research Funding

Yael L. Maxwell

June 29, 2016

News Daily News

FDA Tackles Regulatory, Scientific Issues With Point-of-Care Coagulation Monitoring Devices

March 24, 2016

News Daily News

ROCKET AF Investigators: Problems With Warfarin Monitoring Device Did Not Skew Results

February 04, 2016

News Daily News

Path to Top FDA Post Gets a Bit Rockier for Califf

Michael O'Riordan

December 09, 2015

News Industry News

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

November 29, 2015

News Industry News

Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA

September 29, 2015

News Industry News

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

September 25, 2015

News Industry News

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

July 09, 2015

News Industry News

Portola Pharmaceuticals Announces In Vivo Study Results Demonstrating Andexanet Alfa Significantly Reduced Bleeding and Reversed Anticoagulation Activity of Rivaroxaban While Four-Factor Prothrombin C

June 25, 2015

News Daily News

Data Submitted to FDA in Support of Cardiovascular Devices Often Differ From Those Published in Peer-Reviewed Papers

June 22, 2015

News Industry News

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

July 23, 2014

News Industry News

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

July 07, 2014

News Industry News

CircuLite® Receives Approval to Begin CE Mark Trial for Synergy® IC Circulatory Support System

May 15, 2013

News Daily News

Italian Generic Clopidogrel Worse Than Brand Name at Suppressing Platelets

December 13, 2012

News Industry News

MAQUET Cardiovascular Announces Acquisition of the Avalon Elite® Bi-Caval Dual Lumen Catheter and Complimentary Vascular Access Kits from Avalon Laboratories

May 29, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.